Oorsprong van het eerstegraads netwerk van Yannick Jacques
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
Cytune Pharma SAS
 Cytune Pharma SAS Miscellaneous Commercial ServicesCommercial Services Cytune Pharma SAS develops and manufactures immunotherapeutic agents for the treatment of cancer. It offers CYP 0150 produced by recombinant technology adapted to pharmaceutical processes and is the result of a single translation. The company was founded by David Béchard and Yannick Jacques on November 15, 2007 and is headquartered in Nantes, France.
3
| Subsidiary | Miscellaneous Commercial Services | 3 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Yannick Jacques via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
DMS Biotechnology SRL
 DMS Biotechnology SRL BiotechnologyHealth Technology DMS Biotechnology Sprl develops biotechnology products. The private company is based in Mont-Saint-Guibert, Belgium. | Biotechnology | Corporate Officer/Principal | |
| Vrije Universiteit Brussel | College/University | Doctorate Degree | |
Fujirebio Europe NV
 Fujirebio Europe NV Medical SpecialtiesHealth Technology Fujirebio Europe NV develops and markets diagnostic products to improve therapy management and patient health. It focuses on molecular diagnostics and multiparameter testing. The firm also provides LUMIPULSE G1200, an automated chemiluminescent enzyme immunoassay system; LUMIPULSE G600 II, an automated benchtop CLEIA system, routine and novel markers for the oncology sector. The company was founded in 1985 by Philippe Leboulch and is headquartered in Ghent, Belgium. | Medical Specialties | Corporate Officer/Principal | |
Remora Partners SA
 Remora Partners SA Financial ConglomeratesFinance Remora Partners SA operates as an investment advisor. The private company is based in Lausanne, CH. and has subsidiaries in Switzerland and United States. | Financial Conglomerates | Corporate Officer/Principal | |
| Institute Gustave Rousse | Corporate Officer/Principal | ||
| Hôpital Européen Georges-pompidou | Corporate Officer/Principal | ||
| Atlanpole Biotherapy | Corporate Officer/Principal | ||
| École des Hautes Études Commerciales de Paris | College/University | Graduate Degree | |
| University of Geneva | College/University | Graduate Degree | |
BioLingus (Cayman) Ltd.
 BioLingus (Cayman) Ltd. Miscellaneous Commercial ServicesCommercial Services BioLingus (Cayman) Ltd. is a biotechnology company, which engages in the development of oral delivery of peptides and proteins. The company was founded by Yves Decadt, Sai Ying Ko, and Didier Coquoz on August 8, 2018 and is headquartered in Hergiswil, Switzerland. | Miscellaneous Commercial Services | Founder |
Statistieken
Internationaal
| Frankrijk | 8 |
| België | 4 |
| Zwitserland | 4 |
Sectoraal
| Health Technology | 6 |
| Consumer Services | 4 |
| Finance | 2 |
| Commercial Services | 2 |
Operationeel
| Corporate Officer/Principal | 9 |
| Founder | 3 |
| Chairman | 2 |
| President | 2 |
| Graduate Degree | 2 |
Sterkste connecties
| Insiders | |
|---|---|
| Guy de Martynoff | 9 |
| David Béchard | 4 |
| Didier Coquoz | 3 |
- Beurs
- Insiders
- Yannick Jacques
- Bedrijfsconnecties
